• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒筛查时,检测敏感性次于检测频率和周转时间。

Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening.

机构信息

Department of Computer Science, University of Colorado Boulder.

BioFrontiers Institute, University of Colorado Boulder.

出版信息

Sci Adv. 2021 Jan 1;7(1). doi: 10.1126/sciadv.abd5393. Print 2021 Jan.

DOI:10.1126/sciadv.abd5393
PMID:33219112
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7775777/
Abstract

The COVID-19 pandemic has created a public health crisis. Because SARS-CoV-2 can spread from individuals with presymptomatic, symptomatic, and asymptomatic infections, the reopening of societies and the control of virus spread will be facilitated by robust population screening, for which virus testing will often be central. After infection, individuals undergo a period of incubation during which viral titers are too low to detect, followed by exponential viral growth, leading to peak viral load and infectiousness and ending with declining titers and clearance. Given the pattern of viral load kinetics, we model the effectiveness of repeated population screening considering test sensitivities, frequency, and sample-to-answer reporting time. These results demonstrate that effective screening depends largely on frequency of testing and speed of reporting and is only marginally improved by high test sensitivity. We therefore conclude that screening should prioritize accessibility, frequency, and sample-to-answer time; analytical limits of detection should be secondary.

摘要

COVID-19 大流行引发了一场公共卫生危机。由于 SARS-CoV-2 可以在有症状前、有症状和无症状感染者中传播,因此通过强大的人群筛查来重新开放社会并控制病毒传播将变得更加容易,而病毒检测通常将是筛查的核心。感染后,个体经历潜伏期,在此期间病毒滴度太低而无法检测到,随后病毒呈指数级增长,导致病毒载量和传染性达到峰值,最后病毒滴度下降并清除。鉴于病毒载量动力学模式,我们针对检测灵敏度、频率和样本至报告时间,对重复人群筛查的效果进行建模。这些结果表明,有效的筛查在很大程度上取决于检测频率和报告速度,而高检测灵敏度的改善作用微乎其微。因此,我们得出结论,筛查应优先考虑可及性、频率和样本至报告时间;分析检测限应是次要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb59/7775777/1bd711b5aeaa/abd5393-F7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb59/7775777/b9802d07bc98/abd5393-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb59/7775777/0dca3e9c4073/abd5393-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb59/7775777/1b2ffb527a46/abd5393-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb59/7775777/aae28f8c449b/abd5393-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb59/7775777/f9acb4487fa7/abd5393-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb59/7775777/70f35f8cce94/abd5393-F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb59/7775777/1bd711b5aeaa/abd5393-F7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb59/7775777/b9802d07bc98/abd5393-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb59/7775777/0dca3e9c4073/abd5393-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb59/7775777/1b2ffb527a46/abd5393-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb59/7775777/aae28f8c449b/abd5393-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb59/7775777/f9acb4487fa7/abd5393-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb59/7775777/70f35f8cce94/abd5393-F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb59/7775777/1bd711b5aeaa/abd5393-F7.jpg

相似文献

1
Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening.新冠病毒筛查时,检测敏感性次于检测频率和周转时间。
Sci Adv. 2021 Jan 1;7(1). doi: 10.1126/sciadv.abd5393. Print 2021 Jan.
2
Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance.对于新冠病毒监测而言,检测敏感性不如检测频率和周转时间重要。
medRxiv. 2020 Sep 8:2020.06.22.20136309. doi: 10.1101/2020.06.22.20136309.
3
Universal screening for SARS-CoV-2 infection: a rapid review.SARS-CoV-2 感染的普遍筛查:快速综述。
Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718.
4
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
5
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
6
Routine, Cost-Effective SARS-CoV-2 Surveillance Testing Using Pooled Saliva Limits Viral Spread on a Residential College Campus.采用混样唾液进行常规、具有成本效益的 SARS-CoV-2 监测检测可限制大学校园病毒传播。
Microbiol Spectr. 2021 Oct 31;9(2):e0108921. doi: 10.1128/Spectrum.01089-21. Epub 2021 Oct 13.
7
Feasibility and Effectiveness Assessment of SARS-CoV-2 Antigenic Tests in Mass Screening of a Pediatric Population and Correlation with the Kinetics of Viral Loads.新型冠状病毒抗原检测在儿科人群大规模筛查中的可行性和有效性评估及其与病毒载量动力学的相关性。
Viruses. 2021 Oct 14;13(10):2071. doi: 10.3390/v13102071.
8
Modeling transmission dynamics and effectiveness of worker screening programs for SARS-CoV-2 in pork processing plants.模拟 SARS-CoV-2 在猪肉加工厂工人筛查计划中的传播动力学和效果。
PLoS One. 2021 Sep 2;16(9):e0249143. doi: 10.1371/journal.pone.0249143. eCollection 2021.
9
Multisite Clinical Validation of Isothermal Amplification-Based SARS-CoV-2 Detection Assays Using Different Sampling Strategies.基于不同采样策略的等温扩增法 SARS-CoV-2 检测分析的多中心临床验证。
Microbiol Spectr. 2021 Oct 31;9(2):e0084621. doi: 10.1128/Spectrum.00846-21. Epub 2021 Oct 20.
10
A semi-automated, isolation-free, high-throughput SARS-CoV-2 reverse transcriptase (RT) loop-mediated isothermal amplification (LAMP) test.一种半自动、无需隔离、高通量的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)逆转录(RT)环介导等温扩增(LAMP)检测方法。
Sci Rep. 2021 Nov 1;11(1):21385. doi: 10.1038/s41598-021-00827-0.

引用本文的文献

1
High Concordance Between SYBR Green and TaqMan PCR for SARS-CoV-2 Detection in Nasopharyngeal and Saliva Samples.用于检测鼻咽和唾液样本中新型冠状病毒的SYBR Green法与TaqMan PCR法具有高度一致性。
Viruses. 2025 Aug 18;17(8):1130. doi: 10.3390/v17081130.
2
Potential benefits of adaptive control strategies are outweighed by costs of infrequent, but dramatically larger disease outbreaks.适应性控制策略的潜在益处被罕见但规模巨大的疾病暴发所带来的成本所抵消。
R Soc Open Sci. 2025 Aug 21;12(8):250598. doi: 10.1098/rsos.250598. eCollection 2025 Aug.
3
A policy roadmap for sustainable mass-testing.

本文引用的文献

1
Early Viral Clearance and Antibody Kinetics of COVID-19 Among Asymptomatic Carriers.无症状携带者中 COVID-19 的早期病毒清除及抗体动力学
Front Med (Lausanne). 2021 Mar 15;8:595773. doi: 10.3389/fmed.2021.595773. eCollection 2021.
2
Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions.SARS-CoV-2 感染的 shotgun 转录组、空间组学和等温分析揭示了独特的宿主反应、病毒多样化和药物相互作用。
Nat Commun. 2021 Mar 12;12(1):1660. doi: 10.1038/s41467-021-21361-7.
3
Frequency of Routine Testing for Coronavirus Disease 2019 (COVID-19) in High-risk Healthcare Environments to Reduce Outbreaks.
可持续大规模检测的政策路线图。
Health Aff Sch. 2025 Jul 29;3(8):qxaf151. doi: 10.1093/haschl/qxaf151. eCollection 2025 Aug.
4
A fundamental limit to the effectiveness of traveller screening with molecular tests.分子检测用于旅行者筛查有效性的一个基本限制。
Epidemiol Infect. 2025 Aug 15;153:e95. doi: 10.1017/S0950268825100381.
5
Democratization of Point-of-Care Viral Biosensors: Bridging the Gap from Academia to the Clinic.即时护理病毒生物传感器的民主化:弥合从学术界到临床的差距。
Biosensors (Basel). 2025 Jul 7;15(7):436. doi: 10.3390/bios15070436.
6
A lyophilized open-source RT-LAMP assay for molecular diagnostics in resource-limited settings.一种用于资源有限环境中分子诊断的冻干开源逆转录环介导等温扩增检测法。
Life Sci Alliance. 2025 Jul 14;8(10). doi: 10.26508/lsa.202403167. Print 2025 Oct.
7
Evaluation of RT-LAMP for SARS-CoV-2 Detection in Animal Feces.用于检测动物粪便中新型冠状病毒的逆转录环介导等温扩增技术评估
Viruses. 2025 May 29;17(6):783. doi: 10.3390/v17060783.
8
Testing policies during an epidemic: An economic analysis.疫情期间的检测政策:一项经济分析。
PLoS One. 2025 May 27;20(5):e0322292. doi: 10.1371/journal.pone.0322292. eCollection 2025.
9
Real-world usage of mass rapid antigen testing for COVID-19 in long-term care facilities and support programmes: results from long-term surveillance in North-Eastern Germany.长期护理机构中新冠病毒大规模快速抗原检测的实际应用及支持项目:德国东北部长期监测结果
BMC Public Health. 2025 May 15;25(1):1785. doi: 10.1186/s12889-025-22914-x.
10
Virus Detection by CRISPR-Cas9-Mediated Strand Displacement in a Lateral Flow Assay.在侧流分析中通过CRISPR-Cas9介导的链置换进行病毒检测
ACS Appl Bio Mater. 2025 May 19;8(5):4221-4229. doi: 10.1021/acsabm.5c00307. Epub 2025 Apr 24.
高风险医疗环境中常规检测 2019 年冠状病毒病(COVID-19)以减少疫情爆发的频率。
Clin Infect Dis. 2021 Nov 2;73(9):e3127-e3129. doi: 10.1093/cid/ciaa1383.
4
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.SARS-CoV-2、SARS-CoV 和 MERS-CoV 的病毒载量动态、病毒脱落持续时间和传染性:系统评价和荟萃分析。
Lancet Microbe. 2021 Jan;2(1):e13-e22. doi: 10.1016/S2666-5247(20)30172-5. Epub 2020 Nov 19.
5
Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19).COVID-19 住院患者中感染性病毒排出的持续时间和关键决定因素。
Nat Commun. 2021 Jan 11;12(1):267. doi: 10.1038/s41467-020-20568-4.
6
Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patients.COVID-19 的传染性取决于成年和有症状患者发病时周围的病毒载量。
PLoS One. 2020 Dec 9;15(12):e0243597. doi: 10.1371/journal.pone.0243597. eCollection 2020.
7
SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication.在诊断样本中,SARS-CoV-2 的基因组和亚基因组 RNA 不是活跃复制的指标。
Nat Commun. 2020 Nov 27;11(1):6059. doi: 10.1038/s41467-020-19883-7.
8
Modeling between-population variation in COVID-19 dynamics in Hubei, Lombardy, and New York City.建模湖北省、伦巴第和纽约市之间 COVID-19 动态的人群间变异。
Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25904-25910. doi: 10.1073/pnas.2010651117. Epub 2020 Sep 24.
9
Reductions in commuting mobility correlate with geographic differences in SARS-CoV-2 prevalence in New York City.通勤流动性的下降与纽约市新冠病毒流行率的地理差异相关。
Nat Commun. 2020 Sep 16;11(1):4674. doi: 10.1038/s41467-020-18271-5.
10
Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onset.定量分析 SARS-CoV-2 感染早期阶段自症状出现以来的抗体动力学和 RNA 检测。
Elife. 2020 Sep 7;9:e60122. doi: 10.7554/eLife.60122.